Context Heart failure (HF) is a major cause of morbidity and mortality in Europe and in the
United States. The aim of this review article was to assess the results of the prospective …

Thyrotoxicosis is a common disorder, especially in women. The most frequent cause is
Graves' disease (autoimmune hyperthyroidism). Other important causes include toxic …

Abstract Treatment with amiodarone is associated with changes in thyroid function tests, but
also with thyroid dysfunction (amiodarone-induced hypothyroidism, AIH, and amiodarone …

Amiodarone is a benzofuran derivative approved for the treatment of cardiac arrhythmias.
Traditionally classified as a class III antiarrhythmic agent, amiodarone possesses …

Amiodarone-induced thyroid dysfunction occurs in 15–20% of amiodarone-treated patients.
Amiodarone-induced hypothyroidism (AIH) does not pose relevant problems, is easily …

Assessment of TSH and TPO-Ab before starting amiodarone (AM) treatment is
recommended. The usefulness of periodic TSH measurement every 6 months during AM …

Amiodarone is a highly effective and well-established antiarrrhythmic drug. It can be used to
treat supraventricular and ventricular tachyarrhythmias and has the added advantage of …

Context It is not known whether total thyroidectomy is more favorable than medical therapy
for patients with amiodarone-induced thyrotoxicosis (AIT). Objective To compare total …

Introduction Amiodarone-induced thyrotoxicosis is associated with high morbidity and
mortality rates. The approach to this condition is widely variable across different medical …

Objective Amiodarone is frequently associated with thyroid dysfunction. Identifying
predictors for amiodarone‐associated thyroid dysfunction and assessing treatment outcome …